Cervical cancer elimination
This page displays all content tagged with this topic. If you're looking for more specific information, please use the search page for advanced filtering.
Cervical cancer remains a leading cause of cancer-related mortality among women in low- and middle-income countries. Effective treatment of precancerous lesions detected during cervical screening is critical to reduce the incidence of cervical cancer.
Every year cervical cancer kills nearly 350 000 women globally, 90% of whom live in low- and middle-income countries (LMICs). More than 95% of cervical cancers are caused by oncogenic types of human papillomavirus (HPV).
This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer. It includes some important shifts in WHO’s recommended approaches to cervical screening, and includes a total of 23 recommendations and 7 good practice statements.
In 2025, the World Health Organization released the World Cervical Cancer Elimination Day 2025 toolkit.
Innovative project brings cervical cancer screening to war-affected women in Ukraine
Global resolve for cervical cancer elimination: insights from the second Forum in Bali
New data tool supports countries with their cervical cancer elimination efforts
Global strides towards cervical cancer elimination
Sweden’s journey to eliminate cervical cancer
